International Aid Group Fights Parasites in Brazil
SAO PAULO, Brazil - Officials from INMED are working to help some 2 million Brazilian children infected with intestinal parasites.
For US$5 per child, the drug mebendazole can kill the bugs, which deplete children of vitamin A and iron. The U.S.-based international health and development organization created the Healthy Children, Healthy Futures program to combine public and private monies to aid impoverished public health.
Officials from the World Health Organization estimate that 90 percent of children in rural Brazil are infected with these parasites. Because they are transmitted via soil and water, the organization teaches how to maintain their health after the medication is given. These lessons include information on hand washing, wearing shoes, corralling animals and washing fruits and vegetables.
INMED also works in Mexico, the Dominica Republic, Burkina Faso, Chile, Ecuador, Bolivia, Guatemala, Honduras, the Philippines and India.
For additional information, call Marshall Hoffman at (703) 820-2244.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.
